Endrj Menardi

ORCID: 0000-0003-2184-3093
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Health Systems, Economic Evaluations, Quality of Life
  • Medical Coding and Health Information
  • Cardiac Imaging and Diagnostics
  • Neurological disorders and treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Coronary Interventions and Diagnostics
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Effects of Exercise
  • Cardiac Valve Diseases and Treatments
  • Peripheral Artery Disease Management
  • Cardiovascular and exercise physiology
  • Acute Myocardial Infarction Research
  • Statistical Methods in Clinical Trials
  • Cerebrovascular and Carotid Artery Diseases
  • Stroke Rehabilitation and Recovery
  • S100 Proteins and Annexins
  • ECG Monitoring and Analysis
  • Cardiovascular Syncope and Autonomic Disorders
  • COVID-19 diagnosis using AI

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
2012-2023

Canadian Rheumatology Association
2016-2021

Alessandro Manzoni Hospital
2018

Ospedale Cisanello
2018

Ospedale San Bortolo
2018

Ospedale Santa Maria
2018

Carle Foundation Hospital
2017

Catheter ablation is less successful for persistent atrial fibrillation than paroxysmal fibrillation. Guidelines suggest that adjuvant substrate modification in addition to pulmonary-vein isolation required fibrillation.We randomly assigned 589 patients with a 1:4:4 ratio alone (67 patients), plus of electrograms showing complex fractionated activity (263 or additional linear across the left roof and mitral valve isthmus (259 patients). The duration follow-up was 18 months. primary end point...

10.1056/nejmoa1408288 article EN New England Journal of Medicine 2015-05-06

Background: This multicenter, prospective study evaluated the determinants of zero-fluoroscopy (ZFL) ablation supraventricular tachycardias. Methods and Results: Four hundred thirty patients (215 male, 55.4±22.1 years) with indication to electrophysiological or tachycardias were enrolled. All participating physicians agreed follow as low reasonably achievable policy. A procedure was defined ZFL when no fluoroscopy used. The total time inversely correlated number procedures previously...

10.1161/circep.117.005592 article EN Circulation Arrhythmia and Electrophysiology 2018-03-01

<h3>Importance</h3> Catheter ablation is effective in reducing atrial fibrillation (AF), but the association of for AF with quality life unclear. <h3>Objective</h3> To evaluate whether procedural outcome associated (QOL) measures. <h3>Design, Setting, and Participants</h3> This was a prespecified secondary analysis Substrate Trigger Ablation Reduction Atrial Fibrillation–Part II (STAR II) prospective randomized clinical trial, which compared 3 strategies persistent AF. included 549 589...

10.1001/jamanetworkopen.2020.25473 article EN cc-by-nc-nd JAMA Network Open 2020-12-04
Pietro Francia Matteo Ziacchi Federico Migliore Paolo De Filippo A Dello Russo and 95 more Stefano Viani Antonio Rapacciuolo Giulio Falasconi Carmen Adduci Giovanni Bisignani Luca Checchi Giuseppe Busacca Luca Santini Carlo Lavalle Valéria Calvi Antonio Curcio Massimo Stefano Silvetti Antonio Pangallo Marco Carbonaro Davide Giorgi Raimondo Pittorru Mariolina Lovecchio Sergio Valsecchi Mauro Biffi Antonio D’Onofrio Antonio Pelliccia Giovanni Luca Botto Fabio Lorenzo Canevese M. Casale Fabrizio Caravati B Schintu Antonella Scalone Gianfranco Tola Alessio Setzu Giuseppe Santarpia Amato Santoro C. Baiocchi SLunghetti R Gentilini Pietro Palmisano Michele Accogli Ennio Pisanò Giulio Milanese P. Pepi Daniele Nicolis Massimo Mariani Michele Pagani Massimo Vincenzo Bonfantino Vincenzo Caccavo M. Grimaldi Grigorios Katsouras GB. Forleo Enrico Chieffo E. Tavarelli R. Brambilla Antonio Pani Massimo Giammaria M.T. Lucciola C. Amellone Carlo Uran Matteo Baroni Paolo Ferrari Cristina Leidi Fabrizio Drago Vincenzo Pazzano Scott J. Russo Romolo Remoli Irma Battipaglia Ilaria Cazzoli Fabio Anselmo Saputo Chiara Devecchi Lorella Barbonaglia Miguel Viscusi Marcello Brignoli Andrea Mattera Stefano Pedretti Alessandro Lupi S. Tommasi Amir Kol Maria Chiara Gatto Alessandro Persi Anna Gonella Guido Rossetti Endrj Menardi Roberta Rossini Pasquale Notarstefano Martina Nesti A. Fraticelli G. Carreras Sonia Donzelli Corrado P. Marini A Tordini Ludovico Lazzari P. Sartori Pietro Rossi Paolo Di Donna Giuseppe Mascia Paolo Capogrosso P Magliano M. Colimodio Simone Sala

BACKGROUND: The safety of subcutaneous implantable cardioverter defibrillator (S-ICD) recipients who lead active lifestyles and engage in recreational sports is unknown. We aimed to evaluate the association between lifestyle occurrence arrhythmia- device-related complications, appropriate inappropriate shocks S-ICD recipients. METHODS: assessed a cohort young-adult (15–65 years) patients, evaluated their physical activity with IPAQ (International Physical Activity Questionnaire), on shocks....

10.1161/circep.124.013365 article EN Circulation Arrhythmia and Electrophysiology 2025-02-24

The longevity of defibrillators (ICD) is extremely important from both a clinical and economic perspective. We studied the reasons for device replacement, removed ICD, existence possible factors associated with shorter service life.Consecutive patients who underwent ICD replacement March 2013 to May 2015 in 36 Italian centers were included this analysis. Data on replaced devices collected. A total 953 In 813 (85%) reason was battery depletion, while 88 (9%) remaining 52 because system...

10.1111/jce.12990 article EN cc-by-nc-nd Journal of Cardiovascular Electrophysiology 2016-04-20

The benefit of prolonged implantable cardioverter-defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) following device replacement is hindered by clinical and procedure-related adverse events (AEs). Adverse rate highest in more complex devices at upgrades, as per the REPLACE registry experience, but changing owing to improvement technology medical care. We aimed understanding extent type AEs a contemporary Italian population.Detect long-term complications after ICD...

10.1093/europace/euz166 article EN EP Europace 2019-05-22

Patients at risk of sudden cardiac death (SCD) after myocardial infarction (MI) can be offered therapy with implantable cardioverter defibrillators (ICDs). Whether plasma biomarkers help stratify for SCD and ventricular arrhythmias (VT/VF) is unclear. The primary objective the CAMI-GUIDE study to assess predictive role C-reactive protein or VT/VF in ischaemic patients ejection fraction <30% ICDs. Secondary endpoints included all-cause mortality, hospitalizations, from heart failure....

10.1093/eurheartj/ehr487 article EN European Heart Journal 2012-01-26

Aims Some barriers seem to exist in changing implantable cardioverter defibrillator (ICD) manufacturer at the time of device replacement. We sought understand obstacles ICD within cohort patients enrolled Detect Long-term Complications After Replacement Registry. Methods analyzed 784 consecutive ICD/cardiac resynchronization therapy (CRT-D) replacements a 1.5-year time-frame 36 Italian centers evaluate potential factors associated with manufacturers and system-related complications. Results...

10.2459/jcm.0000000000000572 article EN Journal of Cardiovascular Medicine 2017-10-12

Since 2015 most patients implanted with cardiac devices (implantable cardioverter defibrillators (ICDs), implantable loop recorders (ILRs), pacemakers (PMs)) at Santa Croce e Carle Hospital (Cuneo, Italy) are remotely followed home monitoring systems free of charge. From 2017 the outpatient follow-up service has been systematically organized mainly for peculiar geographical features (typically mountainous, vast and few roads) territory served by our hospital, making difficult access to...

10.1002/joa3.12381 article EN cc-by-nc-nd Journal of Arrhythmia 2020-05-30

Although cardiac resynchronization therapy (CRT) reduces morbidity and mortality reverses left ventricular (LV) remodeling in heart failure patients with LV electrical dyssynchrony, induced proarrhythmia has been reported. The mechanism of CRT-induced remains under debate. In this case report, a description how pacing polymorphic tachycardia immediately after the initiation CRT Changing configuration using multipoint stimulation, we can assume that VTs are related to reentry facilitated by...

10.20944/preprints202401.1265.v1 preprint EN 2024-01-17

Although cardiac resynchronization therapy (CRT) reduces morbidity and mortality reverses left ventricular (LV) remodeling in heart failure patients with LV electrical dyssynchrony, induced proarrhythmia has been reported. The mechanism of CRT-induced remains under debate. In this case report, a description how pacing polymorphic tachycardia immediately after the initiation CRT By changing configuration using multipoint stimulation, we can assume that is related to reentry facilitated by...

10.3390/diseases12050105 article EN cc-by Diseases 2024-05-15
Coming Soon ...